Skip to the content

Generic selectors

Exact matches only

Search in title

Search in content

Search in excerpt

Search in posts

Search in pages

Fidia Pharma USA Inc.

Home Page
The Company
Product Portfolio
- Products
- Our Foundation
Press Releases & Events
- Press Releases
  - Recent
  - Archives
    - 2017
    - 2016
    - 2015
    - 2014
    - 2013
    - 2012
    - 2011
- Events
  - Upcoming
  - Past
Careers
- Current Listings
Contact Us

Home Page
The Company
Product Portfolio
- Products
- Our Foundation
Press Releases & Events
- Press Releases
  - Recent
  - Archives
    - 2017
    - 2016
    - 2015
    - 2014
    - 2013
    - 2012
    - 2011
- Events
  - Upcoming
  - Past
Careers
- Current Listings
Contact Us

Home
The Company
Product Portfolio
- Products
- Our Foundation
Press Releases & Events
- Press Releases
  - Recent
  - Archives
    - 2017
    - 2016
    - 2015
    - 2014
    - 2013
    - 2012
    - 2011
- Events
  - Upcoming
  - Past
Careers
- Current Listings
Contact Us
Legal Terms
Privacy
Fidia Copyright

Upcoming

Posts not found

Our Four Leading Principles:

Innovation

Quality

Globalization

Competitiveness

Visit our
Corporate
Website

Fidia's Other Websites

Direct link to:
hyalgan.com
hyalogyn.com
hymovis.com
triluron.com

Key Business Areas

Drawing on the strengths of the parent company, our product portfolio focuses primarily on therapeutic areas such as joint healthcare and women's health.

Fidia Pharma USA is focused on providing unique, innovative and reliable Hyaluronic Acid (HA)-based treatment options.

© 2023 Fidia Pharma USA Inc.
Fidia Farmaceutici S.p.A was founded in 1946, and Fidia Pharma USA Inc. is a wholly owned subsidiary.
This site is intended for use by US residents only.

Legal Terms
Privacy Policy
Copyright

Are you sure you want to navigate away from this page?

Click OK to continue or Cancel to stay on current page.

Okay Cancel